| Literature DB >> 34850884 |
Hiroyuki Suetsugu1,2,3, Kwangwoo Kim4,5, Takuaki Yamamoto6, So-Young Bang7,8, Yuma Sakamoto9, Jung-Min Shin7, Nobuhiko Sugano10, Ji Soong Kim7, Masaya Mukai11, Yeon-Kyung Lee7, Koichiro Ohmura12, Dae Jin Park7, Daisuke Takahashi13, Ga-Young Ahn7, Kohei Karino14, Young-Chang Kwon8, Tomoya Miyamura15, Jihye Kim8, Junichi Nakamura16, Goro Motomura3, Takeshi Kuroda17, Hiroaki Niiro18, Takeshi Miyamoto19, Tsutomu Takeuchi20, Katsunori Ikari21, Koichi Amano22, Yoshifumi Tada23, Ken Yamaji24, Masato Shimizu25, Takashi Atsumi26, Taisuke Seki27, Yoshiya Tanaka28, Toshikazu Kubo29, Ryo Hisada30, Tomokazu Yoshioka31, Mihoko Yamazaki32, Tamon Kabata33, Tomomichi Kajino34, Yoichi Ohta35, Takahiro Okawa36, Yohei Naito37, Ayumi Kaneuji38, Yuji Yasunaga39, Kenji Ohzono40, Kohei Tomizuka2, Masaru Koido2,41, Koichi Matsuda42,43, Yukinori Okada44,45, Akari Suzuki46, Bong-Jo Kim47, Yuta Kochi48, Hye-Soon Lee7,8, Shiro Ikegawa1, Sang-Cheol Bae7,8, Chikashi Terao2,49,50.
Abstract
Osteonecrosis of the femoral head (ONFH) involves necrosis of bone and bone marrow of the femoral head caused by ischemia with unknown etiology. Previous genetic studies on ONFH failed to produce consistent results, presumably because ONFH has various causes with different genetic backgrounds and the underlying diseases confounded the associations. Steroid-associated ONFH (S-ONFH) accounts for one-half of all ONFH, and systemic lupus erythematosus (SLE) is a representative disease underlying S-ONFH. We performed a genome-wide association study (GWAS) to identify genetic risk factors for S-ONFH in patients with SLE. We conducted a two-staged GWAS on 636 SLE patients with S-ONFH and 95 588 non-SLE controls. Among the novel loci identified, we determined S-ONFH-specific loci by comparing allele frequencies between SLE patients without S-ONFH and non-SLE controls. We also used Korean datasets comprising 148 S-ONFH cases and 37 015 controls to assess overall significance. We evaluated the functional annotations of significant variants by in silico analyses. The Japanese GWAS identified 4 significant loci together with 12 known SLE susceptibility loci. The four significant variants showed comparable effect sizes on S-ONFH compared with SLE controls and non-SLE controls. Three of the four loci, MIR4293/MIR1265 [odds ratio (OR) = 1.99, P-value = 1.1 × 10-9)], TRIM49/NAALAD2 (OR = 1.65, P-value = 4.8 × 10-8) and MYO16 (OR = 3.91, P-value = 4.9 × 10-10), showed significant associations in the meta-analysis with Korean datasets. Bioinformatics analyses identified MIR4293, NAALAD2 and MYO16 as candidate causal genes. MIR4293 regulates a PPARG-related adipogenesis pathway relevant to S-ONFH. We identified three novel susceptibility loci for S-ONFH in SLE.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34850884 PMCID: PMC8976424 DOI: 10.1093/hmg/ddab306
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150